Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02448654 · ClinicalTrials.gov registry record · NA
Treatment for Nicotine Addiction in Women
A NA study of Nicotine Dependence, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT02448654 is a NA study of Nicotine Dependence that has completed, run by Yale University. The registered enrollment target is 36 participants, below the 186-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02448654, a NA study of Nicotine Dependence, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to use a medication tolcapone and or placebo to test if the symptoms of nicotine withdrawal lessens , and or changes in smoking urges, and mental reasoning in female smokers over a 72 hour period.
Conditions Studied
Interventions
- DRUG Tolcapone
- DRUG Sugar Pill
Study Locations (1)
Connecticut
- Veterans Administration Hospital - West Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2015-10-23 |
| Est. Completion | 2019-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02448654
The ClinicalTrials.gov registry entry for NCT02448654 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 186-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (81% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 2 interventions - of which Tolcapone is the first listed.
NCT02448654 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT02448654 about?
NCT02448654 is a clinical study titled "Treatment for Nicotine Addiction in Women". The purpose of this study is to use a medication tolcapone and or placebo to test if the symptoms of nicotine withdrawal lessens , and or changes in smoking urges, and mental reasoning in female smokers over a 72 hour period.
What is the current status of trial NCT02448654?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2015-10-23. Estimated completion is 2019-06-30.
What conditions does trial NCT02448654 study?
This clinical trial studies the following conditions: Nicotine Dependence.
What interventions are being tested in trial NCT02448654?
The interventions under investigation include: Tolcapone (DRUG), Sugar Pill (DRUG).
Who is sponsoring clinical trial NCT02448654?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02448654 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
RECRUITING · NA
-
NeuroControl of Nicotine Dependence
RECRUITING · NA
-
Abuse Liability and Appeal of Oral Nicotine Products
RECRUITING · NA
-
Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction
RECRUITING · NA
-
Young Adult Tobacco/Nicotine and Cannabis Co-use
RECRUITING · NA
-
Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.